16-Jan-2026
No headlines found.
Globe Newswire (Tue, 6-Jan 8:30 AM ET)
Globe Newswire (Thu, 13-Nov 4:00 PM ET)
Globe Newswire (Thu, 13-Nov 2:15 PM ET)
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.
Milestone Scientific trades on the AMEX stock market under the symbol MLSS.
As of January 16, 2026, MLSS stock price declined to $0.29 with 142,953 million shares trading.
MLSS has a beta of 0.87, meaning it tends to be less sensitive to market movements. MLSS has a correlation of 0.03 to the broad based SPY ETF.
MLSS has a market cap of $22.52 million. This is considered a Sub-Micro Cap stock.
Last quarter Milestone Scientific reported $2 million in Revenue and -$.01 earnings per share. This beat revenue expectation by $107,617 and met earnings estimates .
In the last 3 years, MLSS traded as high as $1.39 and as low as $.23.
The top ETF exchange traded funds that MLSS belongs to (by Net Assets): VTI, VXF.
MLSS has underperformed the market in the last year with a price return of -75.7% while the SPY ETF gained +18.1%. MLSS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -35.6% and -2.7%, respectively, while the SPY returned +5.0% and +1.2%, respectively.
MLSS support price is $.28 and resistance is $.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MLSS shares will trade within this expected range on the day.